Compare Humana Inc (HUM) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Global X NASDAQ 100 Covered Call ETF — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Global X NASDAQ 100 Covered Call ETF trades at $18.16. The key difference: Humana Inc pays a 0.92% dividend while Global X NASDAQ 100 Covered Call ETF pays none. Which is the better fit depends on your goals.
| HUM | QYLD | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $409.42 | $18.52 |
52-Week Low | $163.67 | $16.46 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
QYLD trades at $18.14, up 0.33% on the day, with a bullish technical signal from moving averages but bearish oscillators. The ETF offers a high distribution yield, recently around 12%, supported by covered call strategies on the Nasdaq-100. Recent dividends include $0.18 and $0.19 per share, with the latest paid in July 2026. News highlights mixed views, with some analysts upgrading it for income potential while others warn of long-term underperformance versus the Nasdaq-100 index.
Outlook: QYLD appeals for high monthly income in sideways markets, but caps upside during rallies, posing a trade-off between yield and growth. Risks include erosion of net asset value over time and sensitivity to Nasdaq volatility. Investors should weigh income needs against potential capital appreciation limits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
